All Type of News
Gyeonggi Bio Center to open with high dreams.
Gyeonggi Bio Center has opened with dreams of creating one new drug per one company.
The Center took an inauguration ceremony on March 21 in attendance of governor Kim Moon-soo of Gyeonggi province and other dignit...
Drug companies showing hard struggles for sales targets.
The pharmaceutical companies having the fiscal year ended at March 31 showed an impression of struggling hard for the achievement of their annual sales targets.
A pharmaceutical distribution circle said on March...
Ruling party to support bill over suspicious prescription
The proposed bill that doctors must always explain any suspicious contents of a prescription to a pharmacist is feasible as it is deemed necessary and natural, said Chung Se-kyun, incumbent chairman of the ruling Uri ...
KFDA to permit postponement of bio equivalency test reports.
The bio equivalency test reports for about 250 drugs could be submitted to the KFDA by the end of March considering many difficulties and problems to the drug industry. To lighten such heavy burdens to the industry, t...
KPA opposes new medical reform
The Korea Pharmaceutical Association said on March 22 that it will shortly deliver its position to the Ministry of Health and Welfare shortly, making clear that the organization would not launch any collective action ...
UCB Korea holds launching symposium to promote KeppraUCB Korea said recently it has hosted a launching symposium to introduce Keppra (levetiracetam), an alternative add-on therapy for partial epilepsy
The symposium took place a...
|
Drug company employment relying largely on head hunters.
Many leading and even middle levels of local pharmaceutical companies have recently sought to hire outstanding employees through the head hunters, which used to be practiced by largely foreign multinational drug corpo...
Facility investment remains strong
Investment of Korean drug manufacturers in facilities last year grew sharply due to more toughened GMP rating screening, the Korea Food and Drug Administration said recently.
58 Korean drugmakers spent an average o...
Pharmaceutical firms can change trade names
Drugmakers will be allowed to change their initially approved product names (company name plus generic name) to newly or additionally registered trade names prior to launching, the Korea Food and Drug Administration ...
Pfizer Korea to launch new love campaign for Lipitor
Pfizer Korea will launch a new love campaign for its cholesterol-lowering agent Lipitor, which will be initiated by doctors.
The love campaigns features doctor's promises to patients in a story-telling form, for in...
